High Prevalence of Hypoparathyroidism in Patients with beta-Thalassemia Major
,
Abstract
Introduction: Hypoparathyroidism (HPT) is an irreversible but preventable disorder caused by an iron overload which can be considered a typical complication in patients with beta-thalassemia major.
Patients and method: Parathyroid function was evaluated in 130 patients in Qom, Iran, who suffered from beta-thalassemia major. Their serum ferritin levels were checked for monitoring of chelation therapy effects.
Results: The prevalence of HPT was 14.6% (19/130). The median age of patients with HPT was significantly higher than of patients without HPT (18 vs. 15 years; P=0.03). Serum ferritin levels was not significantly different between the two groups (median: 2709 vs. 1512; P=0.95). The prevalence of cardiac diastolic dysfunction in patients with HPT was significantly higher than in normal thalassemic patients (3.1% vs. 15.8%, P=0.04). Patients with hypoparathyroidism demonstrated abnormal glucose metabolism (0% vs. 15.8%; P=0.003).
Conclusion: the high prevalence of hypoparathyroidism demonstrated poor chelation therapy in these patients. Close monitoring of ferritin level was recommended. Also, the measurement of parathyroid hormone on a regular basis for all thalassemic patients was recommended.
Cooley TB, Lee P. A Series of Cases of Splenomegaly in Children with Anemia and Peculiar Changes. Trans Am Pediatr Soc. 1925; 37:29-30.
Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in Medically Treated Patients with Homozygous beta- Thalassemia. N Engl J Med. 1994 Sep 1; 331(9): 574-8.
Jensen CE, Tuck SM, Agnew JE, et al. High Prevalence of Low Bone Mass in Thalassaemia Major. Br J Haematol. 1998 Dec; 103(4): 911-5.
Ang AW, Ko SM, Tan CH. Calcium, Magnesium, and Psychotic Symptoms in a Girl with Idiopathic Hypoparathyroidism. Psychosom Med. 1995 May-Jun;57(3): 299-302.
Mohammadian S, Bazrafshan HR, Sadeghi-Nejad A. Endocrine Gland Abnormalities in Thalassemia Major: a Brief Review. J Pediatr Endocrinol Metab. 2003 Sep; 16(7): 957-64.
Perignon F, Brauner R, Souberbielle JC, et al. Growth and Endocrine Function in Major Thalassemia. Arch Fr Pediatr. 1993 Oct; 50(8): 657-63.
Chern JP, Lin KH. Hypoparathyroidism in Transfusion- dependent Patients with beta-Thalassemia. J Pediatr Hematol Oncol. 2002 May; 24(4): 291-3.
De Sanctis V, Vullo C, Bagni B, et al. Hypoparathyroidism in beta-Thalassemia Major. Clinical and Laboratory Observations in 24 Patients. Acta Haematol. 1992; 88(2-3): 105-8.
Economou M, Katzos G, Koussi A, et al. Hypoparathyroidism in beta-Thalassemic Patients. J Pediatr Hematol Oncol. 2003 Mar; 25(3): 275-6; Author Reply 6.
Angelopoulos NG, Goula A, Rombopoulos G, et al. Hypoparathyroidism in Transfusion-dependent Patients with beta-Thalassemia. J Bone Miner Metab. 2006; 24(2): 138-45.
Alagna S, Masala A, Gallisai D, et al. Parathyroid Function and Bone Metabolism in Children with beta Thalassaemia Major: Effects of Sex Steroid Treatment. Eur J Med. 1992 Jun; 1(3): 153-7.
Domrongkitchaiporn S, Sirikulchayanonta V, Angchaisuksiri P, et al. Abnormalities in Bone Mineral Density and Bone Histology in Thalassemia. J Bone Miner Res. 2003 Sep; 18(9): 1682-8.
Shamshirsaz AA, Bekheirnia MR, Kamgar M, et al. Metabolic and Endocrinologic Complications in beta- Thalassemia Major: a Multicenter Study in Tehran. BMC Endocr Disord. 2003 Aug 12; 3(1): 4.
Vullo C, De Sanctis V, Katz M, et al. Endocrine Abnormalities in Thalassemia. Ann N Y Acad Sci. 1990; 612: 293-310.
Chern JP, Lin KH, Tsai WY, et al. Hypogonadotropic Hypogonadism and Hematologic Phenotype in Patients with Transfusion-dependent beta-Thalassemia. J Pediatr Hematol Oncol. 2003 Nov; 25(11): 880-4.
Filosa A, Di Maio S, Vocca S, et al. Longitudinal Monitoring of Bone Mineral Density in Thalassemic Patients. Genetic structure and osteoporosis. Acta Paediatr. 1997 Apr; 86(4): 342-6.
Italian Working Group on Endocrine Complications in Non-endocrine Disease. Multicentre Study on Prevalence of Endocrine Complications in Thalassaemia Major. Clinical Endocrinology. 1995;42(6): 581-6.
Tanaka Y, Seino Y, Ishida M, et al. Effect of 1,25- dihydroxyvitamin D3 on Insulin Secretion: Direct or Mediated? Endocrinology. 1986 May;118(5):1971-6.
Schluter KD, Piper HM. Cardiovascular Actions of Parathyroid Hormone and Parathyroid Hormone-related Peptide. Cardiovasc Res. 1998 Jan; 37(1): 34-41.
| Files | ||
| Issue | Vol 3, No 3 (2009) | |
| Section | Articles | |
| Keywords | ||
| beta-Thalassemia major Hypoparathyroidism Ferritins | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
